Clinical speech AI for schizophrenia: Diagnostic accuracy of speech- and language-based digital biomarkers in a PRISMA-DTA systematic review and meta-analysis.
Clinically credible evaluation now requires locked-model prospective external validation in diagnostic-uncertainty populations, calibration and decision-curve reporting, standardized multilingual/multidevice acquisition, fairness assessment, interpretable outputs and explicit human oversight.